Photo Credit: Watchara Songprasert
The IASLC 2023 North America Conference on Lung Cancer (NACLC) at the Chicago Marriott Downtown Magnificent Mile ends Sunday, December 3, 2023. Make the most of your final day at the 2023 NACLC conference—use the program information below to plan your schedule:
Sunday, December 3
7-8 a.m.: Networking breakfast
8:15-9:15 a.m.: Choice of track 1 or 2:
Track 1: Oncology in a Digital World: Implications for Telemedicine, Advocacy, and PROs
- Wearables and Use of Technology in Lung Cancer Surgery Care. Lucia Madariaga, University of Chicago
- Implementing PROs into Clinical Practice. Nisha Mohindra, Northwestern.
- Advocates in Action: How to Use Data and Self-Reported Outcomes to Move the Needle. Tejal Patel, MD Anderson Cancer Center.
- Patient Engagement Through Large Language Models (GPT). David Liebovitz, Northwestern.
- Tumor Board – Optimization for Surgery. Jeff Yang, MGH.
- Using Machine Learning Algorithms and Wearable Technology for the Early Detection of Complications. Kalvin Lung, CU Anschutz.
Track 2: Advances in Diagnostic Techniques from Blood to Bronch
- ctDNA to Detect Early Stage Disease. Scott Bratman, University of Toronto.
- Airway. Momen Wahidi, Northwestern.
- Risk Factors for Immune Checkpoint Inhibitor Pneumonitis. Dani Stahlbaum, University of Michigan.
- Cutting Edge Methodologies in Molecular Diagnostic Testing in Newly Diagnosed Lung Cancer. Sinchita Roy, MD Anderson Cancer Center.
- Updates in Advanced Bronchoscopic Techniques for Lung Tissue Acquisition.Coral Giovacchini, Duke University
9:15-9:45 a.m.: Poster viewing & networking break
9:45-11:15 a.m.: Choice of track 1 or 2:
Track 1: ADCs and Targeted Theranostics
- Approved and Emerging ADCs. Rebecca Heist, MGH.
- ADC Toxicity: The Realities. Narjust Florez, DFCI.
- Oncolytic Viruses. Jyoti Malhotra, City of Hope.
- Future Targets for Cell Therapy in Lung Cancer. Ben Creelan, Moffitt.
- Taking a BiTE out of Lung Cancer. Frank Weinberg, University of Illinois Chicago.
- FDA Approval Pathways for Novel Therapies. Justin Malinou, FDA.
Track 2: Optimal Approaches to Early Stage Thoracic Malignancies
- Mesothelioma in 2023. Aaron Mansfield, Mayo Clinic.
- Disparities in Early Stage Treatment. Nathaniel Evans, Jefferson.
- Combined Immunotherapy and SABR in NSCLC. Joe Chang, MD Anderson Cancer Center.
- Patient Selection for Systemic Therapy in Early Stage Disease. Heather Wakelee, Stanford University.
- Optimizing the Patient for the OR. Lucia Madariaga, University of Chicago.
- Survivorship in Early Stage Lung Cancer. Joy Feliciano, Johns Hopkins.
11:15 a.m.-12:15 p.m.: Closing Keynote: Perioperative Therapy. Jonathan Spicer, Assistant Professor of Surgery, McGill University
This program is subject to change without notice. For more conference information, visit 2023 NACLC. Check back here often for conference-related NSCLC abstracts, updates, articles and more!
